Literature DB >> 12477022

Efficacy of treatment for convergence insufficiency using vision therapy.

Paul Adler1.   

Abstract

PURPOSE: The purpose of this study was to determine if vision therapy (VT), as practised within the constraints of UK optometric practice, employing graded routine eye exercises, is as an effective method for treatment of convergence insufficiency (CI) as previously published data suggest. The study also evaluates the associated symptoms before and after therapy.
METHODS: As many optometrists diagnose CI solely on the basis of near point of convergence (NPC) and treat only when symptoms are present (Letourneau et al., 1979; Rouse et al., 1997), in this study CI was defined as NPC of 10 cm or greater (either with or without the presence of asthenopic symptoms for near work) accompanied by exophoria greater at near than at distance. The effect of treatment by optometric vision therapy (OVT) on the NPC and number of symptoms was investigated for 92 patients by retrospectively reviewing the clinical records. Success was defined as the restoration of NPC to normal values and significant reduction in the presenting symptoms.
RESULTS: The effect of treatment on the NPC was shown to be highly significant (t = 14.61, p < 0.001). Although treatment times were slightly longer, the success rates were higher than reported by other authors. Post-treatment values for NPC were: <10 cm (98.9%), <8.5 cm (95.7%) and <6.5 cm (80.4%). Longer treatment times were noted for patients who complained that the text appeared to move (chi2, p = 0.007).
CONCLUSION: Vision therapy is an effective method for treatment of CI.

Entities:  

Mesh:

Year:  2002        PMID: 12477022     DOI: 10.1046/j.1475-1313.2002.00080.x

Source DB:  PubMed          Journal:  Ophthalmic Physiol Opt        ISSN: 0275-5408            Impact factor:   3.117


  14 in total

1.  [A critical view of alternative methods for treating visual complaints].

Authors:  Ch Pieh; W A Lagrèze
Journal:  Ophthalmologe       Date:  2008-03       Impact factor: 1.059

2.  2017 Glenn A. Fry Award Lecture: Establishing an Evidence-based Literature for Vision Therapy - A 25-year Journey.

Authors:  Mitchell M Scheiman
Journal:  Optom Vis Sci       Date:  2018-08       Impact factor: 1.973

Review 3.  Symptomatology associated with accommodative and binocular vision anomalies.

Authors:  Ángel García-Muñoz; Stela Carbonell-Bonete; Pilar Cacho-Martínez
Journal:  J Optom       Date:  2014-07-15

4.  Diagnostic validity of clinical signs associated with a large exophoria at near.

Authors:  Pilar Cacho-Martínez; Angel García-Muñoz; María Teresa Ruiz-Cantero
Journal:  J Ophthalmol       Date:  2013-06-17       Impact factor: 1.909

Review 5.  The treatment methods for post-stroke visual impairment: A systematic review.

Authors:  Kerry Louise Hanna; Lauren Rachel Hepworth; Fiona J Rowe
Journal:  Brain Behav       Date:  2017-04-06       Impact factor: 2.708

6.  Impact of Vision Therapy on Eye-hand Coordination Skills in Students with Visual Impairment.

Authors:  Javad Heravian Shandiz; Abbas Riazi; Abbas Azimi Khorasani; Negareh Yazdani; Maryam Torab Mostaedi; Behrooz Zohourian
Journal:  J Ophthalmic Vis Res       Date:  2018 Jul-Sep

7.  Preferred clinical practice in convergence insufficiency in India: a survey.

Authors:  Sourabh D Patwardhan; Pradeep Sharma; Rohit Saxena; Sumeet K Khanduja
Journal:  Indian J Ophthalmol       Date:  2008 Jul-Aug       Impact factor: 1.848

8.  Rasch analysis for development and reduction of Symptom Questionnaire for Visual Dysfunctions (SQVD).

Authors:  Mario Cantó-Cerdán; Pilar Cacho-Martínez; Francisco Lara-Lacárcel; Ángel García-Muñoz
Journal:  Sci Rep       Date:  2021-07-21       Impact factor: 4.379

9.  Negative Fusional Vergence Is Abnormal in Children with Symptomatic Convergence Insufficiency.

Authors:  Mitchell M Scheiman; Tara L Alvarez; Susan A Cotter; Marjean T Kulp; Loraine T Sinnott; Maureen D Plaumann; Jasleen Jhajj
Journal:  Optom Vis Sci       Date:  2021-01-01       Impact factor: 2.106

10.  Vision In Stroke cohort: Profile overview of visual impairment.

Authors:  Fiona J Rowe
Journal:  Brain Behav       Date:  2017-10-06       Impact factor: 2.708

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.